Tüdőrák: vizsgálatok itt: Olaszország

In Olaszország 272 Also abroad 2746

272 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 15.. Ask the study team whether a trial fits you.

1/2. fázisTaking people
A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
Where
Rozzano
Életkor
18 év and over
People
240 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07325136 · EU 2025-524090-16-00
No phaseTaking people
NUT Project: Nutritional Support in Thoracic Oncology
Where
Peschiera del Garda
Életkor
18 év and over
People
100
Run by
Casa di Cura Dott. Pederzoli
See details and how to joinNCT07817329
1. fázisTaking people
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Where
Florence, Milan, Naples
Életkor
18 év and over
People
383 worldwide
Run by
Iambic Therapeutics, Inc
See details and how to joinNCT06253871
3. fázisTaking people
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study with Durvalumab
Where
Arezzo, Bari, Catania, Meldola, Milan, Modena, Padova, Pisa, Rome
Életkor
18 év and over
People
87 worldwide
Run by
Astrazeneca AB
See details and how to joinNCT05303532 · EU 2023-507337-22-00
2. fázisNot yet taking people in Olaszország
Immune dynamics and biomarkers of anti-tumor response in BMS-986340 (anti-CCR8) and nivolumab (anti-PD-1) co-treatment of metastatic tumors
Where
Rozzano
Életkor
18 év and over
People
30
Run by
Humanitas Mirasole S.p.A.
See details and how to join2025-524125-40-01
1. fázisTaking people
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Where
Naples
Életkor
18 év and over
People
400 worldwide
Run by
Pierre Fabre Medicament
See details and how to joinNCT04913285
1/2. fázisNot yet taking people in Olaszország
Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs
Where
Naples, Orbassano
Életkor
18 év and over
People
171 worldwide
Run by
Pierre Fabre Medicament
See details and how to joinNCT06567015 · EU 2023-510203-21-00
2. fázisTaking people
A randomized trial of multi-factorial primary prevention in high risk subjects candidate to a lung cancer early detection CT program
Where
Milan
Életkor
18 év and over
People
2000
Run by
Fondazione IRCCS Istituto Nazionale Dei Tumori
See details and how to join2024-513660-26-00
3. fázisTaking people
Study of Sacituzumab Govitecan Versus Standard of Care in Participants with Previously Treated Extensive Stage Small Cell Lung Cancer
Where
Aviano, Candiolo, Legnano, Lucca, Milan, Naples, Pesaro, Peschiera del Garda, Rome
Életkor
18 év and over
People
355 worldwide
Run by
Gilead Sciences Inc.
See details and how to join2024-515884-69-00
2. fázisNot yet taking people in Olaszország
LuMIERE: A Phase 1/2, Multicenter, Open label, Non randomized Study to Investigate Safety and Tolerability, Pharmacokinetics, Dosimetry, and Preliminary Activity of [177Lu]Lu-FAP-2286 in Participants with an Advanced Solid Tumor
Where
Meldola, Milan, Naples, Negrar, Reggio Emilia
Életkor
18 év and over
People
36 worldwide
Run by
Novartis Pharma AG
See details and how to joinNCT04939610 · EU 2023-508995-12-01
1/2. fázisTaking people
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
Where
Milan, Modena, Naples
Életkor
18 év to 100 év
People
280 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06726148 · EU 2024-517281-42-00
No phaseTaking people
Surgical Outcome Of da Vinci Single-port Surgical System In Lung Cancer
Where
Milan
People
50
Run by
European Institute of Oncology
See details and how to joinNCT07790406
3. fázisFut, nem toboroz
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Where
Milan, Monza, Orbassano, Padova, Parma
Életkor
18 év and over
People
582 worldwide
Run by
AstraZeneca
See details and how to joinNCT06350097 · EU 2023-509883-89-00
1/2. fázisTaking people
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Where
Candiolo, Milan, Naples, Rome, Verona
Életkor
18 év and over
People
594 worldwide
Run by
BioNTech SE
See details and how to joinNCT06892548 · EU 2024-520238-31-01
2. fázisNot yet taking people in Olaszország
A randomized phase II study of Pembrolizumab (MK-3475) as maintainance therapy in patients with unresectable stage III non-small cell lung cancer treated with definitive chemo-radiotherapy (MP-LALC- Maintainance Pembrolizumab in Locally Advanced Lung Cancer).
Where
Aviano, Bari, Florence, Genoa, Messina, Milan, Modena, Naples, Orbassano, Rome, Rozzano, Taranto, Turin
Életkor
18 év and over
People
126
Run by
Universita' Degli Studi Di Torino
See details and how to joinNCT03379441 · EU 2024-514701-57-01
2. fázisTaking people
Phase II randomized trial comparing atezolizumab versus atezolizumab plus bevacizumab as first-line treatment in PD-L1 high advanced non-small-cell lung cancer patients
Where
Ancona, Bari, Brindisi, Catania, Civitavecchia, Feltre, Grosseto, Lecco, Macerata, Meldola, Milan, Modena, Monza, Naples, Napoli, Negrar, Orbassano, Palermo, Piacenza, Ponderano, Ravenna, Reggio Emilia, Rionero in Vulture (PZ), Rome, Siracusa, Statte, Teramo, Varese, Verona
Életkor
18 év and over
People
130
Run by
Fondazione Ricerca Traslazionale
See details and how to join2024-517200-10-00
3. fázisTaking people
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Where
Aviano, Milan, Modena
Életkor
18 év and over
People
36 worldwide
Run by
Arrivent Biopharma Inc.
See details and how to join2025-522151-26-00
1/2. fázisTaking people
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Where
Candiolo, Milan, Naples, Roma, Rozzano, Siena
Életkor
18 év and over
People
1109 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT04895709
1. fázisTaking people
Long-Term Follow-Up (LTFU) of Participants Treated with Adoptive Cell Therapies
Where
Milan
People
7 worldwide
Run by
USWM Ct LLC
See details and how to join2024-513033-21-00
1. fázisNot yet taking people in Olaszország
A Phase 1 Study to Determine the Safety, and Pharmacokinetics of the Selective MET kinase Inhibitor, DO-2 in Patients With Advanced or Refractory Solid Tumours
Where
Ancona, Meldola, Orbassano, Roma
Életkor
18 év and over
People
138 worldwide
Run by
Deuteroncology
See details and how to join2023-504897-39-00
3. fázisFut, nem toboroz
Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide versus Durvalumab, Carboplatin, and Etoposide in First-Line ES-SCLC (DeLLphi-312)
Where
Bari, Bergamo, Meldola, Milan, Rome, Verona
Életkor
18 év and over
People
156 worldwide
Run by
Amgen Inc.
See details and how to join2024-520050-38-00
No phaseNot yet taking people in Olaszország
Virtual Reality in Lung Cancer Patients
Where
Olbia
Életkor
18 hónap to 80 év
People
60
Run by
Dott.Claudio Sini
See details and how to joinNCT07755501
2. fázisTaking people
Phase II single arm study with CABozantinib in Non-Small Cell Lung Cancer patients with MET deregulation
Where
Avellino, Bari, Florence, Meldola, Messina, Milan, Modena, Monza, Orbassano, Padova, Palermo, Parma, Perugia, Pisa, Ravenna, Reggio Emilia, Rimini, Rome, Saronno, Verona
Életkor
18 év and over
People
25
Run by
Fondazione Ricerca Traslazionale
See details and how to joinNCT03911193 · EU 2024-518386-95-02
3. fázisTaking people
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Where
Bari, Bergamo, Brescia, Catania, Catanzaro, Genoa, Milan, Monza, Naples, Parma, Perugia, Rome, Rozzano, Verona
Életkor
18 év and over
People
540 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06203210 · EU 2023-509628-16-00
1. fázisTaking people
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
Where
Milan, Pisa, Verona
Életkor
18 év and over
People
434 worldwide
Run by
Amgen
See details and how to joinNCT07094113